Worldwide Insights Into the Patient Recruitment & Retention Services Market, 2019-2030 - Growing Demand for Orphan Drugs and Personalized Medicine
DUBLIN, May 7, 2019 /PRNewswire/ -- The "Patient Recruitment and Retention Services Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.
Patient Recruitment and Retention Services, 2019-2030
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain.
One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030.
In addition, we have segmented the future opportunity across:
-- [A] therapeutic area (oncology, infectious diseases, cardiovascular
diseases, CNS disorders, respiratory disorders, metabolic disorders, and
others)
-- [B] steps in patient recruitment process (pre-screening and screening)
-- [C] phases of development (phase I, phase II, phase III and phase IV)
-- [D] different global regions (North America, Europe, Asia-Pacific and
rest of the world)
In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.
Market Insights
Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose immense financial pressure on sponsors.
Amongst several known challenges, patient recruitment is considered to be one of the rate-limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don't even enroll a single patient.
In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit/retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.
The above-mentioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research.
Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs / personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future.
In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.
Key Topics Covered
1. Preface
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. Executive Summary
3. Patient Recruitment And Retention In Clinical Trials
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services
4. Patient Outreach Methods
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach
5. Competitive Market Landscape Of Patient Recruitment And Retention Service Providers
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
6. Company Competitiveness Analysis
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies
7. Company Profiles
7.1. Chapter Overview
7.2. Patient Recruitment Service Providers in North America
7.2.1. Acurian
7.2.2. BBK Worldwide
7.2.3. Bright Pharmaceuticals Services
7.2.4. ClinEdge
7.2.5. CSSi
7.2.6. CTM
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.8. MMG
7.2.9. Topstone Research
7.2.10. WCCT Global
7.3. Patient Recruitment Service Providers in Europe
7.3.1. Antidote
7.3.2. Fidelis Research
7.3.3. Ignite Data
7.3.4. Polaris BioPharma Consulting
7.3.5. Tudor Reilly Health
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROe
7.4.2. Jsure Healthmedia
7.4.3. TrialWire
7.4.4. Pacific Groove
8. Partnerships And Collaborations
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis
9. Recent Trends In Patient Recruitment And Retention
9.1. Chapter Overview
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets
10. Future Growth Opportunities
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing
11. Market Sizing And Opportunity Analysis
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
12. Conclusion
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade
13. Interview Transcripts
13.1. Chapter Overview
13.2. Link2Trials
13.3. nRollmed
13.4. Seeker Health
Companies Mentioned
1. Abnex
2. Access Clinical Research
3. Accurate Clinical Research
4. Acurian
5. AD VERBUM
6. Advanced Clinical
7. Affordable Clinical Trials Outsourcing
8. Akcelis
9. Alleco Trials
10. Alliance for Clinical Research Excellence and Safety
11. Allscripts
12. American Liver Foundation
13. American Society of Clinical Oncology
14. Amgen
15. Antidote
16. ApotheCom
17. Apparelyzed
18. Apptomics
19. AQLANE Medical
20. Arden and Schmidt
21. AstraZeneca
22. ATLAS Medical Services
23. AutoCruitment
24. AXELLE Group
25. Axiom Marketing
26. BBK Worldwide
27. BDD
28. BIAPharm
29. Bio-Optronics
30. Bioclinica
31. BioScript
32. Bladder & Bowel Community
33. Blueprint Clinical
34. BlueTheory Clinical Trials
35. BMC Group
36. Box
37. Bridge Clinical Research
38. Bright Pharmaceutical Services
39. Buzzreach
40. C&C Clinical Laboratory Consulting
41. Canadian Institute for Medical Advancement
42. Capsule Communications
43. CaringKind
44. CarthagoPharma
45. Center Point Clinical Services
46. Centricity Health
47. Chandler Chicco Agency
48. Chase Medical Research
49. Cinven
50. Circuit Clinical
51. Clariness
52. Clear Clinica
53. Clinart MENA
54. ClinEdge
55. Clinerion
56. Clinical Ambassador
57. Clinical List America
58. Clinical Trial
59. Clinical Trial Connect
60. Clinical Trial Marketing Communications
61. Clinical Trial Networking
62. Clinical Trials Center
63. Clinical Trials Group
64. ClinicalConnection
65. Clinically Media
66. ClinIntel
67. CliniSpan Health
68. Clinspire Research
69. Clintec
70. Clintract
71. Clinverse
72. CMX Research
73. Compass Research
74. Continuum Clinical
75. CPS Research
76. CROee
77. CSSi
78. CTM
79. Cyclone
80. Cytespace
81. DAC Patient Recruitment Services
82. DAVA Oncology
83. DrFirst
84. Eastern Medical
85. Effectus CTR
86. EGeen
87. Elligo Health Research
88. EmergingMed
89. eNre
90. ePatientFinder
91. eStudySite
92. Euclid SR Partners
93. European Organization for Research and Treatment of Cancer
94. EVERSANA
95. FDAMap
96. Fidelis Research
97. Flatiron Health
98. Foundation for the National Institutes of Health
99. Foundation Medicine
100. Friends of Cancer Research
101. Gaea Clinical
102. Galen Patient Recruitment
103. GCP Clinical Studies
104. Genentech
105. Gitzo Pharmaceuticals
106. Global Clinical Trials
107. Global Perspectives
108. GuideStar Research
109. Heron Therapeutics
110. Ignite Data
111. IMS Health
112. Incontinence UK
113. Innovative Trials
114. INSPIRE
115. Institute of Clinical Research India
116. Integrated Clinical Trial Services
117. IQVIA
118. IRM
119. J Trotter Research & Consulting
120. JLL Partners
121. JP Morgan Partners
122. KCR
123. Klick Health
124. Langland
125. LeadSlinger
126. Linical Accelovance
127. Link2Trials
128. Live Doctors
129. LongTaal
130. Lyft
131. Lymphoma Action
132. Medical Research South
133. MediciGroup
134. Melanoma Research Alliance
135. Merck Capital Ventures
136. Miami Research Associates
137. MMG
138. Mondosano
139. Mundipharma Research
140. National Cancer Institute
141. Northumbria Healthcare NHS Foundation Trust
142. nRollmed
143. O4 Research
144. One Research
145. orphan reach
146. Orphanos
147. Osaka International Cancer Institute
148. Pacific Grove
149. Parallel 6
150. PAREXEL
151. Patient Enrollment Advisors
152. Patient RM
153. PatientEvolution
154. Patients Direct
155. PatientWise
156. Patiro
157. Pepgra
158. Pfizer
159. Pharm-Olam
160. PharmaCentra
161. Pharmaceutical Product Development
162. phaware global association
163. Physicians Plasma Alliance
164. Polaris Biopharma Consulting
165. PPH plus
166. Practice Fusion
167. Praxis Communications
168. PRC Clinical
169. Profil
170. ProQuest Investments
171. Publicis Healthcare Communications Group
172. PWNHealth
173. QPS
174. Radiant Research
175. RealTime Software Solutions
176. RemediumOne
177. Remedy Health Media
178. Rep Network
179. RESolutions
180. Roche
181. S4 Research
182. Seeker Health
183. Sinque Labs
184. SitePartner
185. SMO Clinical Research
186. SMO ClinPlus
187. Society for Clinical Research Sites
188. Spectrum Clinical Research
189. Spinal Cord Injury Network
190. Splash Clinical
191. SubjectWell
192. SWOG Cancer Research
193. Syneos Health
194. Synexus
195. TFS
196. The Academic Network
197. The Patient Experience Project
198. The Patient Recruiting Agency
199. The Patient Recruitment Consultancy
200. ThreeWire
201. Topstone Research
202. Total Clinical Trial Management
203. Trial Connections
204. Trialfacts
205. TrialJoin
206. TrialSpark
207. TrialWire
208. Tudor Reilly Health
209. United BioSource
210. University of Exeter
211. University of Glasgow
212. University of Strathclyde
213. Veristat
214. Viomedo
215. VisibilityRx
216. Vizae Clinical Trial Management
217. WCCT Global
218. WIRB-Copernicus Group
219. Worldwide Clinical Trials
220. X Factor Advertising
For more information about this report visit https://www.researchandmarkets.com/r/aj67yw
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
